Projected Income Statement: Bayer AG

Forecast Balance Sheet: Bayer AG

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 32,966 31,273 34,263 32,354 46,336 32,237 29,295 26,680
Change - -5.14% 9.56% -5.57% 43.22% -30.43% -9.13% -8.93%
Announcement Date 01/03/22 28/02/23 05/03/24 04/03/25 04/03/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Bayer AG

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 2,611 2,949 2,751 2,778 2,487 2,712 2,762 2,880
Change - 12.95% -6.71% 0.98% -10.48% 9.04% 1.86% 4.27%
Free Cash Flow (FCF) 1 2,478 4,144 2,366 4,590 3,443 -1,940 3,649 4,222
Change - 67.23% -42.91% 94% -24.99% -156.35% 288.05% 15.71%
Announcement Date 01/03/22 28/02/23 05/03/24 04/03/25 04/03/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Bayer AG

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 25.36% 26.63% 24.57% 21.72% 21.22% 20.83% 21.59% 22.58%
EBIT Margin (%) 16.55% 18.24% 15.93% 11.66% 11.21% 12.15% 13.28% 14.42%
EBT Margin (%) 4.64% 9.2% -3.4% -5.01% -6.87% 5.95% 8.7% 10.06%
Net margin (%) 2.27% 8.18% -6.17% -5.48% -7.94% 4.22% 6.38% 7.38%
FCF margin (%) 5.62% 8.17% 4.97% 9.85% 7.55% -4.28% 7.83% 8.7%
FCF / Net Income (%) 247.8% 99.86% -80.45% -179.86% -95.11% -101.29% 122.72% 117.96%

Profitability

        
ROA 0.84% 3.39% -2.44% -2.25% -3.36% 1.38% 2.63% 3.18%
ROE 20.14% 21.74% 17.52% 15.32% 16.66% 15.43% 15.72% 16.09%

Financial Health

        
Leverage (Debt/EBITDA) 2.95x 2.31x 2.93x 3.2x 4.79x 3.41x 2.91x 2.44x
Debt / Free cash flow 13.3x 7.55x 14.48x 7.05x 13.46x -16.62x 8.03x 6.32x

Capital Intensity

        
CAPEX / Current Assets (%) 5.92% 5.81% 5.77% 5.96% 5.46% 5.98% 5.93% 5.94%
CAPEX / EBITDA (%) 23.36% 21.82% 23.5% 27.44% 25.72% 28.71% 27.45% 26.29%
CAPEX / FCF (%) 105.37% 71.16% 116.27% 60.52% 72.23% -139.76% 75.7% 68.22%

Items per share

        
Cash flow per share 1 5.18 7.22 5.209 7.5 6.036 2.881 7.064 6.858
Change - 39.38% -27.86% 43.99% -19.52% -52.26% 145.16% -2.92%
Dividend per Share 1 2 2.4 0.11 0.11 0.11 0.2147 0.7026 1.214
Change - 20% -95.42% 0% 0% 95.19% 227.24% 72.81%
Book Value Per Share 1 33.61 39.47 33.52 32.48 26.41 28.41 31.27 34.06
Change - 17.42% -15.08% -3.09% -18.68% 7.55% 10.07% 8.94%
EPS 1 1.02 4.22 -2.99 -2.6 -3.68 1.996 3.01 3.561
Change - 313.73% -170.85% 13.04% -41.54% 154.23% 50.83% 18.3%
Nbr of stocks (in thousands) 9,82,424 9,82,424 9,82,424 9,82,424 9,82,424 9,82,424 9,82,424 9,82,424
Announcement Date 01/03/22 28/02/23 05/03/24 04/03/25 04/03/26 - - -
1EUR
Estimates
2026 *2027 *
P/E ratio 18.6x 12.3x
PBR 1.31x 1.19x
EV / Sales 1.51x 1.41x
Yield 0.58% 1.89%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
37.08EUR
Average target price
48.47EUR
Spread / Average Target
+30.73%

Quarterly revenue - Rate of surprise